The Enviromedica Terraflora Broad Spectrum Synbiotic supplement is positioned as a health-focused product for consumers who are looking to increase their overall intake of both probiotics and prebiotics.
The supplement contains two novel GRAS-affirmed Bacillus strains that will both reportedly contribute towards better gastrointestinal health and even immune function. Each capsule contains one billion viable cells per serving and has a spore-based profile that makes it perfect for consumers seeking to maintain better gut health without traditional dairy-based options.
The Enviromedica Terraflora Broad Spectrum Synbiotic supplement is shelf-stable to eliminate the need for refrigeration and comes with 60 capsules per bottle. The supplement is focused on a free-from profile thanks to the absence of wheat, dairy, gluten, yeast, sugar, corn, shellfish, soy GMOS and tree nuts.
Broad-Spectrum Digestive Aids
The Enviromedica Terraflora Broad Spectrum Synbiotic is Soil-Based
Trend Themes
1. Bacillus-based Supplements - There is a growing trend of using Bacillus-based supplements for better gastrointestinal health and immune function, indicating an opportunity for companies to explore the use of these novel GRAS-affirmed strains in their product offerings.
2. Shelf-stable Probiotics - With the Enviromedica Terraflora Broad Spectrum Synbiotic supplement being shelf-stable, there is a potential trend of developing probiotic products that do not require refrigeration, offering convenience to consumers and creating a market opportunity for companies.
3. Free-from Supplements - The trend of free-from supplements, such as the Enviromedica Terraflora Broad Spectrum Synbiotic supplement which is free from wheat, dairy, gluten, yeast, sugar, corn, shellfish, soy, and GMOs, opens up an opportunity for companies to create supplements that cater to specific dietary needs and restrictions.
Industry Implications
1. Nutraceuticals - The nutraceutical industry could take advantage of the increasing demand for supplements that contain Bacillus-based strains for digestive and immune health, as well as the trend of free-from supplements.
2. Food and Beverage - The food and beverage industry can explore the use of Bacillus-based strains in their products, and market them as a means of promoting digestive and immune health, and also tap into the market potential of shelf-stable probiotic products for added convenience.
3. Pharmaceuticals - There is a potential for pharmaceutical companies to explore the use of Bacillus-based strains for developing treatments for digestive and immune-related conditions, given the reported health benefits of these strains.